» Articles » PMID: 32762797

Age-specific SARS-CoV-2 Infection Fatality Ratio and Associated Risk Factors, Italy, February to April 2020

Abstract

We analysed 5,484 close contacts of coronavirus disease (COVID-19) cases in Italy, all tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection fatality ratio was 0.43% (95% confidence interval (CI): 0.21-0.79) for individuals younger than 70 years and 10.5% (95% CI: 8.0-13.6) for older individuals. Risk of death after infection was 62% lower (95% CI: 31-80) in clusters identified after 16 March 2020 and 1.8-fold higher for males (95% CI: 1.03-3.16).

Citing Articles

Prioritising older individuals for COVID-19 booster vaccination leads to optimal public health outcomes in a range of socio-economic settings.

Bouros I, Hill E, Keeling M, Moore S, Thompson R PLoS Comput Biol. 2024; 20(8):e1012309.

PMID: 39116038 PMC: 11309497. DOI: 10.1371/journal.pcbi.1012309.


Out-of-Hospital Cardiac Arrest Before and During the COVID-19 Pandemic in Hong Kong: Registry-Based Study From 2017 to 2023.

Xu R, Sun R, Fu S JMIR Public Health Surveill. 2024; 10:e56054.

PMID: 38771620 PMC: 11150895. DOI: 10.2196/56054.


Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.

Marziano V, Guzzetta G, Menegale F, Sacco C, Petrone D, Urdiales A Influenza Other Respir Viruses. 2023; 17(8):e13181.

PMID: 37599801 PMC: 10432583. DOI: 10.1111/irv.13181.


Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply.

Galli M, Zardini A, Gamshie W, Santini S, Tsegaye A, Trentini F Sci Rep. 2023; 13(1):5586.

PMID: 37019980 PMC: 10075159. DOI: 10.1038/s41598-023-32501-y.


Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models.

Zirkenbach V, Ignatz R, Ottl R, Cehreli Z, Stroikova V, Kaya M Int J Mol Sci. 2023; 24(5).

PMID: 36902442 PMC: 10002951. DOI: 10.3390/ijms24055011.


References
1.
Buitrago-Garcia D, Egli-Gany D, Counotte M, Hossmann S, Imeri H, Ipekci A . Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020; 17(9):e1003346. PMC: 7508369. DOI: 10.1371/journal.pmed.1003346. View

2.
Verity R, Okell L, Dorigatti I, Winskill P, Whittaker C, Imai N . Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20(6):669-677. PMC: 7158570. DOI: 10.1016/S1473-3099(20)30243-7. View

3.
Perez-Saez J, Lauer S, Kaiser L, Regard S, Delaporte E, Guessous I . Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2020; 21(4):e69-e70. PMC: 7833057. DOI: 10.1016/S1473-3099(20)30584-3. View

4.
Russell T, Hellewell J, Jarvis C, van Zandvoort K, Abbott S, Ratnayake R . Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Euro Surveill. 2020; 25(12). PMC: 7118348. DOI: 10.2807/1560-7917.ES.2020.25.12.2000256. View

5.
Meyerowitz-Katz G, Merone L . A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020; 101:138-148. PMC: 7524446. DOI: 10.1016/j.ijid.2020.09.1464. View